Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2016 Apr 14;36(6):1254–1262. doi: 10.1161/ATVBAHA.116.307518

Figure 1.

Figure 1

ANG 1–7 dilated atrial and adipose arterioles from human subjects without CAD. The Mas receptor antagonist A779 (10−5 mol/L) significantly reduced the vasodilator response to ANG 1–7 in both vessel types. n=5 atrial, n=4 adipose. *P<0.05 vs. A779 treated. A779 vessels were paired with the control responses. n=number of vessels, each from a different individual.